Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07176572Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial (2 arms), sponsored by Adiyaman University Research Hospital. Primary endpoint: Change of the intensity of pain at 30 months. Planned start Mar 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07176572.